Slah Ouerhani-Saadi
Carthage, Tunisia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Journal: Molecular biology reports
Published: January 03, 2022
Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Journal: Molecular biology reports
Published: August 23, 2021
The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer.
Journal: Annals of diagnostic pathology
Published: June 09, 2021
miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters.
Journal: Molecular biology reports
Published: September 11, 2019
The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
Journal: Molecular biology reports
Published: February 08, 2019
Polymorphisms in XPC gene and risk for prostate cancer.
Journal: Molecular biology reports
Published: November 08, 2018
Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients.
Journal: Molecular biology reports
Published: July 10, 2018
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.
Journal: Molecular biology reports
Published: December 20, 2012
Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.
Journal: Molecular biology reports
Published: July 05, 2012
Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population.
Journal: Bulletin du cancer
Published: December 08, 2011
Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors.
Journal: Cancer investigation
Published: November 14, 2009
The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients.
Journal: Bulletin du cancer
Published: February 29, 2008
Last Updated: 09/26/2026